Translate Bio, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability and PK/PD Evaluation of Intravenous Administration of MRT5201 in Patients With OTC Deficiency (NCT03767270) | Translate Bio, Inc. | 2019-12-01 |
Track Translate Bio, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.